Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease

被引：0
|
作者：
Undas, Anetta [1 ,2 ]
机构：
[1] Jagiellonian Univ, Med Coll, Dept Thromboembol Dis, Inst Cardiol, Krakow, Poland
[2] John Paul 2 Hosp, Ctr Res & Innovat Technol, Krakow, Poland
来源：
ANATOLIAN JOURNAL OF CARDIOLOGY | 2023年 / 27卷 / 01期
关键词：
D O I：
10.14744/AnatolJCardiol.2022.2333
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：54 / 55
页数：2
相关论文
共 50 条
  • [1] Reply to Letter to the Editor: "Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease"
    Guzel, Tuncay
    Aktan, Adem
    Kilic, Raif
    Arslan, Bayram
    Demir, Muhammed
    Ozbek, Mehmet
    Ertas, Faruk
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2023, 27 (01): : 56 - 58
  • [2] Real-life assessment of triple anticoagulation therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
    Bogacki, P.
    Kablak-Ziembicka, A.
    Bryniarski, K. L.
    Wrotniak, L.
    Ostrowska-Kaim, E.
    Zmudka, K.
    Przewlocki, T.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 1163 - 1163
  • [3] Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation
    Baron-Esquivias, Gonzalo
    Fernandez-Aviles, Francisco
    Atienza, Felipe
    Pastor Pueyo, Pablo
    Toro, Rocio
    Sanmartin Fernandez, Marcelo
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (04) : 341 - 353
  • [4] Oral anticoagulation in patients undergoing elective cardioversion of atrial fibrillation. Real-life experience from Finland
    Itainen-Stromberg, S.
    Hekkala, A. -M.
    Aro, A.
    Vasankari, T.
    Airaksinen, J.
    Lehto, M.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 1194 - 1194
  • [5] Renal Impairment in a "Real-Life" Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding)
    Roldan, Vanessa
    Marin, Francisco
    Fernandez, Hermogenes
    Manzano-Fernandez, Sergio
    Gallego, Pilar
    Valdes, Mariano
    Vicente, Vicente
    Lip, Gregory Y. H.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (08): : 1159 - 1164
  • [6] Real-Life Incident Atrial Fibrillation in Outpatients with Coronary Artery Disease
    Ninni, Sandro
    Lemesle, Gilles
    Meurice, Thibaud
    Tricot, Olivier
    Lamblin, Nicolas
    Bauters, Christophe
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 11
  • [7] DABIGATRAN TROUGH AND PEAK LEVELS IN "REAL-LIFE" PATIENTS WITH ATRIAL FIBRILLATION
    Sinigoj, P.
    Malmstrom, R. E.
    Vene, N.
    Bozic-Mijovski, M.
    Pohanka, A.
    Antovic, J. P.
    Mavri, A.
    [J]. THROMBOSIS RESEARCH, 2016, 141 : S2 - S2
  • [8] External Validity of the ARISTOTLE Trial in Real-Life Atrial Fibrillation Patients
    Hagg, Lovisa
    Johansson, Cecilia
    Jansson, Jan-Hakan
    Johansson, Lars
    [J]. CARDIOVASCULAR THERAPEUTICS, 2014, 32 (05) : 214 - 218
  • [9] Real-life anticoagulation treatment of atrial fibrillation after catheter ablation: Possible overtreatment of low-risk patients
    Dagres, Nikolaos
    Hindricks, Gerhard
    Kottkamp, Hans
    Sommer, Philipp
    Gaspar, Thomas
    Bode, Kerstin
    Arya, Arash
    Rallidis, Loukianos S.
    Kremastinos, Dimitrios Th
    Piorkowski, Christopher
    [J]. THROMBOSIS AND HAEMOSTASIS, 2009, 102 (04) : 754 - 758
  • [10] Anticoagulation with rivaroxaban in a hematology unit: clinical profile, events and discontinuation rates in real-life patients with nonvalvular atrial fibrillation
    Gavin Sebastian, Olga
    Izuzquiza Fernandez, Macarena
    Martinez Fernandez, Raquel
    Palomera Bernal, Luis
    [J]. FUTURE CARDIOLOGY, 2018, 14 (03) : 25 - 30
12345